As reported in a previous Leucegene study on CK AML [12], more than 80% (30/37) of TP53 mutations presented a variant allele frequency (VAF) > 0.75 (Fig. S2 and Table S1), reflecting the predominant expression of the mutated allele. The gene discussed is TP53; the disease is acute myeloid leukemia.